Fitting the epidemiology and neuropathology of the early stages of Alzheimer’s disease to prevent dementia

Advances in the prevention of Alzheimer's disease and dementia

(2014) A. Solomon et al.   JOURNAL OF INTERNAL MEDICINE

National Institutes of Health State-of-the-Science Conference Statement: Preventing Alzheimer Disease and Cognitive Decline

(2013) Martha L. Daviglus   ANNALS OF INTERNAL MEDICINE

Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study

(2013) Stephanie JB Vos et al.   LANCET NEUROLOGY

Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial

(2013) S.M. Mills et al.   REVUE NEUROLOGIQUE

Overdiagnosis in Mammographic Screening for Breast Cancer in Europe: A Literature Review

(2012) Donella Puliti et al.   JOURNAL OF MEDICAL SCREENING

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

(2012) Peter T. Nelson et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Making Alzheimer's and dementia research fit for populations

(2012) Carol Brayne et al.   LANCET

Modeling using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4

(2012) Jonathan Karnon et al.   VALUE IN HEALTH

Alzheimer's disease diagnostic criteria: practical applications

(2012) Jeffrey Cummings   Alzheimers Research & Therapy

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Clifford R. Jack et al.   Alzheimers & Dementia

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease

(2011) Clifford R. Jack et al.   ANNALS OF NEUROLOGY

Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

(2011) Heiko Braak et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

The projected effect of risk factor reduction on Alzheimer's disease prevalence

(2011) Deborah E Barnes et al.   LANCET NEUROLOGY

Revising the definition of Alzheimer's disease: a new lexicon

(2010) Bruno Dubois et al.   LANCET NEUROLOGY

Mild Cognitive Impairment

(2009) Ronald C. Petersen et al.   ARCHIVES OF NEUROLOGY

Prevalence of dementia and major dementia subtypes in Spanish populations: A reanalysis of dementia prevalence surveys, 1990-2008

(2009) Jesús de Pedro-Cuesta et al.   BMC Neurology

CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

(2009) Niklas Mattsson   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

Preventive neurology: On the way from knowledge to action

(2009) M. Kivipelto et al.   NEUROLOGY

Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines

(2009) Natasha K. Stout et al.   PHARMACOECONOMICS

Budget Impact Analysis of Thrombolysis for Stroke in Spain: A Discrete Event Simulation Model

(2009) Javier Mar et al.   VALUE IN HEALTH

Two-Year Progression from Mild Cognitive Impairment to Dementia: To What Extent Do Different Definitions Agree?

(2008) Fiona E. Matthews et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Measuring target effect of proposed disease-modifying therapies in Alzheimer’s disease

(2008) Randall J. Bateman et al.   Neurotherapeutics